Rocket Pharmaceuticals Inc

RCKTNASDAQ · USD
1.95USD0.00 (-7.59%)
125

Rocket Pharmaceuticals Inc (RCKT) Option Chain

Read more

Tracking the RCKT option chain helps you see every strike and expiry on Rocket Pharmaceuticals Inc in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of RCKT options activity at a glance. Use our scanner to monitor the RCKT option chain in real time and filter for the trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For RCKT stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where RCKT options are being actively traded, and where they are not.

Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells; leukocyte adhesion deficiency-I, a genetic disorder that causes the immune system to malfunction; and pyruvate kinase deficiency, a rare red blood cell autosomal recessive disorder that results in chronic non-spherocytic hemolytic anemia.

2026-12-18
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
100.00720.200.00—0.202.50+28.21—0.950.550.40010.00
100.003500.750.00—0.755.00+156.412.203.803.05-0.05000.00
100.00000.750.00—0.757.50+284.623.007.105.55-0.50000.00

As of Nov 20, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV Rank1.19% Low
  • Market cap (M$)218
  • 52 weeks high-64.22%
  • 52 weeks low-3.94%
  • Analyst recommendationBuy
    2.14
  • Target price$8.31
    326.15% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-11-12
  • P/E—
  • Future P/E—
  • EPS (ttm)-0.16
  • EPS growth next 5 years12.63%

As of Nov 20, 2026